熱門資訊> 正文

Crispr董事乔治购买5150万美元股票

2025-07-18 22:08

Crispr Therapeutics (NASDAQ:CRSP) has disclosed a $51.5 million stock purchase by board director Simeon George in an SEC filing.
Crispr surged as much as 21% on Friday, marking its biggest intraday gain since February, after. The stock is now up around 58.4% year-to-date.

More on CRISPR Therapeutics

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)
Crispr Therapeutics: Face The Harsh Reality Instead Of Waiting (Rating Downgrade)
Crispr Therapeutics: Betting On A One-Shot Future
CRISPR delays early-stage readout for heart disease therapy
Crispr extends gains for the seventh consecutive trading day

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。